EMA Reduces Trial Requirements For Hemophilia Drugs

 
• By Ian Schofield
  
Hemophilia
The EMA has revised its guidance on hemophilia medicines • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D